{
    "clinical_study": {
        "@rank": "107841", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die.\n\n      PURPOSE: Phase II trial to study the effectiveness of CCI-779 in treating patients who have\n      metastatic melanoma."
        }, 
        "brief_title": "CCI-779 in Treating Patients With Metastatic Melanoma", 
        "condition": "Melanoma (Skin)", 
        "condition_browse": {
            "mesh_term": "Melanoma"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the anti-tumor activity of CCI-779, in terms of progression-free survival, in\n           patients with metastatic melanoma.\n\n        -  Determine the toxic effects of this regimen in these patients.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients receive CCI-779 IV over 30 minutes on day 1. Courses repeat every 7 days in the\n      absence of disease progression or unacceptable toxicity.\n\n      Patients are followed for survival.\n\n      PROJECTED ACCRUAL: Approximately 40-50 patients will be accrued for this study within 12\n      months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically or cytologically confirmed metastatic melanoma that is incurable by\n             surgery, radiotherapy, or limb perfusion\n\n          -  Measurable disease\n\n               -  At least 20 mm by conventional techniques OR\n\n               -  At least 10 mm by spiral CT scan\n\n               -  The following are not considered measurable:\n\n                    -  Bone lesions\n\n                    -  Leptomeningeal disease\n\n                    -  Ascites\n\n                    -  Pleural/pericardial effusion\n\n                    -  Inflammatory breast disease\n\n                    -  Lymphangitis cutis/pulmonis\n\n                    -  Abdominal masses not confirmed and followed by imaging techniques\n\n                    -  Cystic lesions\n\n          -  Progressive disease\n\n          -  No prior or concurrent CNS metastasis\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  18 and over\n\n        Performance status:\n\n          -  ECOG 0-2\n\n        Life expectancy:\n\n          -  More than 4 months\n\n        Hematopoietic:\n\n          -  WBC at least 3,000/mm^3\n\n          -  Absolute neutrophil count at least 1,500/mm^3\n\n          -  Platelet count at least 100,000/mm^3\n\n        Hepatic:\n\n          -  Bilirubin normal\n\n          -  AST and ALT no greater than 2.5 times upper limit of normal\n\n          -  Cholesterol no greater than 350 mg/dL (lipid-lowering therapy allowed)\n\n          -  Triglycerides no greater than 300 mg/dL except for hydroxymethyl-glutaryl-coenzyme A\n             reductase inhibitors\n\n        Renal:\n\n          -  Creatinine normal OR\n\n          -  Creatinine clearance at least 60 mL/min\n\n        Cardiovascular:\n\n          -  No symptomatic congestive heart failure\n\n          -  No unstable angina pectoris\n\n          -  No cardiac arrhythmia\n\n        Other:\n\n          -  Not pregnant or nursing\n\n          -  Negative pregnancy test\n\n          -  Fertile patients must use effective contraception\n\n          -  HIV negative\n\n          -  No prior allergic reactions to compounds of similar chemical or biological\n             composition to study drug\n\n          -  No ongoing or active infection\n\n          -  No seizure disorder\n\n          -  No autoimmune disease\n\n          -  No psychiatric illness or social situation that would preclude study\n\n          -  No other concurrent uncontrolled illness that would preclude study\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  No more than 1 prior adjuvant biological therapy regimen\n\n          -  No more than 1 prior biological therapy regimen for advanced disease\n\n          -  At least 6 months since prior biological therapy or biochemotherapy and recovered\n\n          -  Prior isolated limb perfusion with biological agent allowed if not to sole site of\n             disease\n\n        Chemotherapy:\n\n          -  See Biologic therapy\n\n          -  Prior isolated limb perfusion with chemotherapy allowed if not to sole site of\n             disease\n\n          -  No more than 1 prior chemotherapy-containing regimen for advanced disease, regardless\n             of adjuvant therapy\n\n               -  May be in addition to 1 prior biologic regimen for advanced disease OR\n\n               -  May have had 1 prior biochemotherapy regimen for advanced disease\n\n          -  At least 3 weeks since prior chemotherapy and recovered\n\n        Endocrine therapy:\n\n          -  At least 1 week since prior dexamethasone\n\n          -  No concurrent glucocorticosteroid therapy\n\n        Radiotherapy:\n\n          -  See Disease Characteristics\n\n        Surgery:\n\n          -  See Disease Characteristics\n\n        Other:\n\n          -  At least 1 week since prior phenobarbital, phenytoin, carbamazepine, or rifampin\n\n          -  At least 3 weeks since other prior agents to treat malignancy\n\n          -  At least 3 weeks since prior investigational agents\n\n          -  No other concurrent investigational agents\n\n          -  No concurrent drugs that are metabolized by or alter the level of cytochrome P450-3A"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "August 10, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00022464", 
            "org_study_id": "CDR0000068820", 
            "secondary_id": [
                "U01CA063265", 
                "P30CA033572", 
                "CHNMC-PHII-27", 
                "CHNMC-IRB-99167", 
                "NCI-29"
            ]
        }, 
        "intervention": {
            "intervention_name": "temsirolimus", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Sirolimus", 
                "Everolimus"
            ]
        }, 
        "keyword": [
            "stage IV melanoma", 
            "recurrent melanoma"
        ], 
        "lastchanged_date": "February 5, 2010", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/CHNMC-PHII-27"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Duarte", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91010-0269"
                    }, 
                    "name": "City of Hope Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90089"
                    }, 
                    "name": "USC/Norris Comprehensive Cancer Center and Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pasadena", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91105"
                    }, 
                    "name": "City of Hope Medical Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95817"
                    }, 
                    "name": "University of California Davis Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60640"
                    }, 
                    "name": "Louis A. Weiss Memorial Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60637-1470"
                    }, 
                    "name": "University of Chicago Cancer Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Decatur", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62526"
                    }, 
                    "name": "Decatur Memorial Hospital Cancer Care Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Evanston", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60201"
                    }, 
                    "name": "Evanston Northwestern Health Care - Evanston Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Harvey", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60426"
                    }, 
                    "name": "Ingalls Memorial Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "LaGrange", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60525"
                    }, 
                    "name": "LaGrange Memorial Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maywood", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60153"
                    }, 
                    "name": "Loyola University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Peoria", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "61602"
                    }, 
                    "name": "Oncology/Hematology Associates of Central Illinois, P.C."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62701"
                    }, 
                    "name": "Central Illinois Hematology Oncology Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Wayne", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46885-5099"
                    }, 
                    "name": "Fort Wayne Medical Oncology and Hematology, Incorporated"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "South Bend", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46601"
                    }, 
                    "name": "CCOP - Northern Indiana CR Consortium"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manhasset", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11030"
                    }, 
                    "name": "North Shore University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Weill Medical College of Cornell University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104-4283"
                    }, 
                    "name": "Abramson Cancer Center of the University of Pennsylvania"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamilton", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L8V 5C2"
                    }, 
                    "name": "Cancer Care Ontario-Hamilton Regional Cancer Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "N6A 4L6"
                    }, 
                    "name": "Cancer Care Ontario-London Regional Cancer Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 2M9"
                    }, 
                    "name": "Princess Margaret Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "official_title": "A Phase II Study Of CCI-779 (NSC 683864) In Metastatic Melanoma", 
        "overall_official": {
            "affiliation": "Beckman Research Institute", 
            "last_name": "Kim A. Margolin, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "September 2005", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00022464"
        }, 
        "results_reference": {
            "PMID": "16007689", 
            "citation": "Margolin K, Longmate J, Baratta T, Synold T, Christensen S, Weber J, Gajewski T, Quirt I, Doroshow JH. CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium. Cancer. 2005 Sep 1;104(5):1045-8."
        }, 
        "source": "City of Hope Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "City of Hope Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2001", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2010"
    }, 
    "geocoordinates": {
        "Abramson Cancer Center of the University of Pennsylvania": "39.952 -75.164", 
        "CCOP - Northern Indiana CR Consortium": "41.683 -86.25", 
        "Cancer Care Ontario-Hamilton Regional Cancer Centre": "43.244 -79.889", 
        "Cancer Care Ontario-London Regional Cancer Centre": "42.979 -81.246", 
        "Central Illinois Hematology Oncology Center": "39.782 -89.65", 
        "City of Hope Comprehensive Cancer Center": "34.139 -117.977", 
        "City of Hope Medical Group": "34.148 -118.145", 
        "Decatur Memorial Hospital Cancer Care Institute": "39.84 -88.955", 
        "Evanston Northwestern Health Care - Evanston Hospital": "42.041 -87.69", 
        "Fort Wayne Medical Oncology and Hematology, Incorporated": "41.079 -85.139", 
        "Ingalls Memorial Hospital": "41.61 -87.647", 
        "LaGrange Memorial Hospital": "38.965 -89.417", 
        "Louis A. Weiss Memorial Hospital": "41.878 -87.63", 
        "Loyola University Medical Center": "41.879 -87.843", 
        "North Shore University Hospital": "40.798 -73.7", 
        "Oncology/Hematology Associates of Central Illinois, P.C.": "40.694 -89.589", 
        "Princess Margaret Hospital": "43.653 -79.383", 
        "USC/Norris Comprehensive Cancer Center and Hospital": "34.052 -118.244", 
        "University of California Davis Cancer Center": "38.582 -121.494", 
        "University of Chicago Cancer Research Center": "41.878 -87.63", 
        "Weill Medical College of Cornell University": "40.714 -74.006"
    }
}